Unilever
UL | NYSE
$66.59
+$1.33 (+2.04%)
Nov 2, 2026, 3:43 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q4 2025 Dec 31, 2025 | Q2 2025 Jun 30, 2025 | Q4 2024 Dec 31, 2024 | Q2 2024 Jun 30, 2024 | Q4 2023 Dec 31, 2023 | Q2 2023 Jun 30, 2023 | Q4 2022 Dec 31, 2022 | Q2 2022 Jun 30, 2022 | Q4 2021 Dec 31, 2021 | Q2 2021 Jun 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 26.13B | 20.23B | 30.13B | 29.64B | 31.12B | 29.18B | 30.43B | 30.45B | 29.62B | 26.65B | 25.79B |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | 34.43B | n/a | 35.91B | n/a | 30.26B | n/a |
Gross Profit | n/a | 20.38B | 30.13B | 29.64B | 31.12B | -5.25B | 30.43B | -5.46B | 29.62B | -3.61B | 25.79B |
Operating Income | 5.24B | 4.17B | 5.32B | 3.45B | 5.95B | 4.24B | 5.52B | 6.26B | 4.5B | 4.28B | 4.43B |
Interest Income | 183.58M | 217.38M | 195.5M | 239.23M | 234.55M | 133M | 309M | 262M | 222M | 137M | 114M |
Pretax Income | 4.75B | 3.57B | 5.09B | 3.3B | 5.57B | 4.07B | 5.27B | 5.98B | 4.36B | 4.19B | 4.37B |
Net Income | 3.08B | 2.56B | 3.51B | 2.04B | 3.7B | 2.94B | 3.55B | 4.74B | 2.91B | 2.93B | 3.12B |
Selling & General & Admin | n/a | n/a | 57M | 36M | 35M | 15.18B | 50M | 14.46B | 22M | 11.71B | 5M |
Research & Development | n/a | n/a | n/a | n/a | n/a | 949M | n/a | 908M | n/a | 847M | n/a |
Other Expenses | 20.25B | 15.59B | 24.76B | 26.16B | 25.13B | -25.63B | 24.86B | -27.08B | 25.1B | -20.44B | 21.36B |
Operating Expenses | 20.25B | 15.59B | 24.81B | 26.19B | 25.17B | -9.5B | 24.91B | -11.71B | 25.12B | -7.88B | 21.37B |
Interest Expense | 567.04M | 464.54M | 377M | 269M | 393M | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | 8.55B | n/a | 7.82B | n/a | 6.87B | n/a |
Cost & Expenses | 20.89B | 16.05B | 24.81B | 26.19B | 25.17B | 24.93B | 24.91B | 24.2B | 25.12B | 22.38B | 21.37B |
Income Tax Expense | 1.4B | 1.19B | 1.28B | 950M | 1.55B | 814M | 1.39B | 925M | 1.14B | 963M | 972M |
Shares Outstanding (Basic) | 2.18B | 2.18B | 2.47B | 2.49B | 2.52B | 2.53B | 2.53B | 2.54B | 2.57B | 2.59B | 2.62B |
Shares Outstanding (Diluted) | 2.18B | 2.2B | 2.47B | 2.5B | 2.51B | 2.53B | 2.54B | 2.55B | 2.57B | 2.59B | 2.63B |
EPS (Basic) | 1.42 | 1.17 | 1.43 | 0.82 | 1.48 | 1.16 | 1.40 | 1.86 | 1.14 | 1.13 | 1.19 |
EPS (Diluted) | 1.41 | 1.17 | 1.42 | 0.82 | 1.47 | 1.16 | 1.40 | 1.86 | 1.13 | 1.13 | 1.19 |
EBITDA | 5.89B | 4.64B | 6.47B | 6.09B | 6.92B | 5.08B | 6.03B | 4.8B | 5.91B | 5.04B | 5.71B |
EBIT | 5.24B | 4.17B | 5.68B | 5.13B | 6.12B | 4.85B | 5.28B | 4.57B | 5.07B | 4.79B | 4.85B |
Depreciation & Amortization | 644.55M | 460.57M | 795M | 963M | 794M | 236M | 753M | 227M | 842M | 251M | 860M |
Add to Watchlist
Select watchlists to add or remove UL